Magnosco GmbH
Mailinglist
Legal issues
Imprint
Data Security
  • LinkedIn
  • Twitter - Magnosco
  • YouTube

Company

As a start-up focusing on research, our goal is not only to improve melanoma diagnostics, but to provide effective support for other skin tumors and diseases.

Magnosco

We are facing new tasks to implement what we have learned and to pursue new research approaches.

 

Before expanding our market activity, our first priority is further development of the device.

 

In this phase we are completely dedicated to development and will not place any further devices on the market. The existing DermaFCs will be used for research purposes. Commercial use is not possible at this point.

Next Steps

We are facing new tasks to implement what we have learned and to pursue new research approaches.

 

Before expanding our market activity, our first priority is further development of the device.

 

In this phase we are completely dedicated to development and will not place any further devices on the market. The existing DermaFCs will be used for research purposes. Commercial use is not possible at this point.

Our Team

Our managing directors Thomas Diepold and Dr. Sebastian Ahlberg lead the team of engineers, developers and scientists.

Working at magnosco

Are you looking for an exciting job at an innovative healthcare start-up? Are laser spectroscopy and artificial intelligence no foreign words for you?

Then you've come to the right place

Certificates & Compliance

Magnosco GmbH is DIN EN ISO 13485:2016
certified

 
Contact

Magnosco GmbH

Justus-von-Liebig-Straße 2

DE-12489 Berlin

+49 (0)30 912075 357